Results 141 to 150 of about 25,675 (362)
TP53‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management
ABSTRACT Alterations in the tumor suppressor gene TP53 are common in human cancers and are associated with an aggressive nature. Approximately 8%–12% of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) harbor TP53 mutations (TP53mut) and present immense challenges due to inherent chemoresistance and poor outcomes.
Mithun Vinod Shah+2 more
wiley +1 more source
Statistical Issues in the Diagnosis of Shaken Baby Syndrome/Abusive Head Trauma [PDF]
The diagnosis of Shaken Baby Syndrome/Abusive Head Trauma (SBS/AHT) is fraught with controversy due to critical statistical deficiencies in the data underpinning these diagnoses. This paper examines the reliability and scientific foundation of SBS/AHT through a statistical lens, highlighting the lack of independently verified ground truth, contextual ...
arxiv
Is A Quantum Stabilizer Code Degenerate or Nondegenerate for Pauli Channel? [PDF]
Mapping an error syndrome to the error operator is the core of quantum decoding network and is also the key step of recovery. The definitions of the bit-flip error syndrome matrix and the phase-flip error syndrome matrix were presented, and then the error syndromes of quantum errors were expressed in terms of the columns of the bit-flip error syndrome ...
arxiv
ABSTRACT With the recent publication of new classification systems of hematopoietic neoplasms, understanding how recognition of disease entities has occurred over time and the subsequent development of formal disease classifications is of importance. This review focuses on the early recognition of myeloid disorders, especially chronic myeloid disorders,
Daniel A. Arber, Attilio Orazi
wiley +1 more source
Overview on incidence, diagnosis, and therapy in vaccine‐related myocarditis. CMR, cardiac magnetic resonance; EMB, endomyocardial biopsy; NSAIDS, non‐steroidal anti‐inflammatory drugs. Abstract Over 10 million doses of COVID‐19 vaccines based on RNA technology, viral vectors, recombinant protein, and inactivated virus have been administered worldwide.
Bettina Heidecker+17 more
wiley +1 more source
Syndrome Measurement Order for the [[7,1,3]] Quantum Error Correction Code [PDF]
In this work we explore the accuracy of quantum error correction depending of the order of the implemented syndrome measurements. CSS codes require bit-flip and phase flip-syndromes be measured separately. To comply with fault tolerant demands and to maximize accuracy this set of syndrome measurements should be repeated allowing for flexibility in the ...
arxiv
Targeted Therapies in Myelofibrosis: Present Landscape, Ongoing Studies, and Future Perspectives
ABSTRACT Myelofibrosis (MF) is a myeloproliferative neoplasm that is accompanied by driver JAK2, CALR, or MPL mutations in more than 90% of cases, leading to constitutive activation of the JAK–STAT pathway. MF is a multifaceted disease characterized by trilineage myeloid proliferation with prominent megakaryocyte atypia and bone marrow fibrosis, as ...
Giuseppe G. Loscocco, Paola Guglielmelli
wiley +1 more source
Challenging Physiotherapy for Children with Ataxia Telangiectasia
The aim of this article is to provide insight in the challenges for physiotherapists in assessment and treatment of the rare, degenerative and grave neurological disease Ataxia Telangiectasia (AT).
Ellen Velema, Trudy Burgers
doaj
STAT3-Deficient hyperimmunoglobulin E syndrome: report of a case with orofacial granulomatosis–like disease [PDF]
Hyperimmunoglobulin E syndrome (HIES) is a rare heterogeneous primary immunodeficiency disorder characterized by infections of the lung and skin, elevated serum immunoglobulin E, and involvement of soft and bony tissues.
Cale, C+5 more
core
ABSTRACT Allogeneic hematopoietic stem‐cell transplantation (HCT) remains the only potentially curative therapy for patients with myelodysplastic neoplasms (MDS) and myelofibrosis (MF) and is the standard care for eligible patients with higher‐risk disease. Despite significant advancements, both diseases pose unique challenges due to their clinical and
Nico Gagelmann, Nicolaus Kröger
wiley +1 more source